SEC Form D filing

Spine BioPharma, Inc., 2026-06-05

An SEC Form D private-offering notice from New York, NY, a $8,500,000 filer-stated offering target in Biotech. Filed 2026-06-05. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Spine BioPharma, Inc. Verified via SEC Form D

Clinical-stage biopharmaceutical company developing non-opiate, non-surgical intradiscal injection therapy for chronic low back pain caused by degenerative disc disease.

Filed 2026-06-05Filed to raise $8,500,000First money in 2026-05-22Raised so far $384,798HQ (as filed) New York, NYSector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Named in the filing 5 executives & directors
Open this row on the live feed →More new filings in New York →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source